PERSPECTIVE THERAPEUTICS INC (CATX) Stock Earnings & Estimates
USA - NYSEARCA:CATX - US46489V3024 - Common Stock
2.28 USD
+0.07 (+3.17%)
2.36 USD
+0.08 (+3.51%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10.8M 7.46% | 1.434M -86.72% | 1.454M 1.39% | 1.159M -20.29% | 893.989K -22.87% | 526.708K -41.08% | 22.105M 4,096.83% | 207.49M 838.66% | 206.5M -0.48% | 372.49M 80.38% | 521.49M 40.00% | |
| EBITDA YoY % growth | -7.1M -118.46% | -39.955M -462.75% | -64.491M -61.41% | -94.712M -46.86% | -114.357M -20.74% | -108.028M 5.53% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -7.39M -114.83% | -40.941M -454.01% | -66.797M -63.15% | -101.431M -51.85% | -126.319M -24.54% | -137.119M -8.55% | -158.636M -15.69% | -29.705M 81.27% | -11.394M 61.64% | 122.7M 1,176.86% | 237.07M 93.21% | |
| Operating Margin | -68.43% | -2,855.02% | -4,594.02% | -8,751.56% | -14,129.82% | -26,033.28% | -717.65% | -14.32% | -5.52% | 32.94% | 45.46% | |
| EPS YoY % growth | -0.05 -25.00% | N/A -2,619.93% | -0.84 38.23% | -1.22 -45.24% | -1.34 -9.58% | -1.26 5.73% | -1.18 6.66% | -1.05 10.69% | -0.64 38.83% | 0.27 141.27% | 0.91 244.23% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.33 -58.49% | -0.34 -37.50% | -0.36 -44.76% | -0.34 -18.88% | -0.37 -10.85% | -0.36 -3.86% |
| Revenue Q2Q % growth | 228.307K -38.13% | 229.673K -1.85% | 108.528K -68.27% | 81.6K -71.86% | 119.003K -47.88% | 119.003K -48.19% |
| EBITDA Q2Q % growth | -22.134M -29.92% | -22.695M -22.09% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -26.48M -42.10% | -28.489M -36.35% | -27.532M -26.11% | -28.791M -19.77% | -28.332M -7.00% | -28.642M -0.54% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.29 -61.11% | -0.31 | 0.02 | 5.80% |
| Q1 2025 Q2Q % growth | -0.25 -25.00% | -0.31 | 0.06 | 20.23% |
| Q4 2024 Q2Q % growth | -0.25 71.59% | -0.27 | 0.02 | 7.98% |
| Q3 2024 Q2Q % growth | -0.21 47.50% | -0.22 | 0.01 | 3.49% |
| Q2 2024 Q2Q % growth | -0.18 -800.00% | -0.21 | 0.03 | 15.97% |
| Q1 2024 Q2Q % growth | -0.20 | -0.24 | 0.04 | 15.95% |
| Q4 2023 Q2Q % growth | -0.88 -8,700.00% | -0.37 | -0.51 | -135.27% |
| Q3 2023 Q2Q % growth | -0.40 -3,900.00% | -0.41 | 0.01 | 1.96% |
| Q2 2023 Q2Q % growth | -0.02 -100.00% | -0.01 | -0.01 | -96.08% |
| Q4 2022 Q2Q % growth | -0.01 | -0.01 | 0.00 | 1.96% |
| Q3 2022 Q2Q % growth | -0.01 | -0.01 | 0.00 | -30.72% |
| Q2 2022 Q2Q % growth | -0.01 | -0.01 | 0.00 | -30.72% |
| Q1 2022 Q2Q % growth | -0.02 -100.00% | -0.01 | -0.01 | -96.08% |
| Q4 2021 Q2Q % growth | -0.01 50.00% | -0.01 | 0.00 | 1.96% |
| Q3 2021 Q2Q % growth | -0.01 | -0.01 | 0.00 | 1.96% |
| Q2 2021 Q2Q % growth | -0.01 | -0.01 | 0.00 | 1.96% |
| Q1 2021 Q2Q % growth | -0.01 | -0.01 | 0.00 | 1.96% |
| Q4 2020 Q2Q % growth | -0.02 | -0.02 | 0.00 | -30.72% |
| Q3 2020 Q2Q % growth | -0.01 50.00% | -0.01 | 0.00 | 26.45% |
| Q2 2020 Q2Q % growth | -0.01 50.00% | -0.01 | 0.00 | 26.45% |
| Q1 2020 Q2Q % growth | -0.01 50.00% | -0.02 | 0.01 | 50.98% |
| Q4 2019 Q2Q % growth | -0.02 | -0.02 | 0.00 | 1.96% |
| Q3 2019 Q2Q % growth | -0.02 | -0.02 | 0.00 | 1.96% |
| Q2 2019 Q2Q % growth | -0.02 | -0.02 | 0.00 | 1.96% |
| Q1 2019 Q2Q % growth | -0.02 | -0.02 | 0.00 | 1.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 290K -44.87% | 157.549K | 132.451K | 84.07% |
| Q1 2025 Q2Q % growth | 342K 5.23% | 147.186K | 194.814K | 132.36% |
| Q4 2024 Q2Q % growth | 234K -88.50% | 249.064K | -15.064K | -6.05% |
| Q3 2024 Q2Q % growth | 369K -83.11% | 269.392K | 99.608K | 36.98% |
| Q2 2024 Q2Q % growth | 526K -74.83% | 161.843K | 364.157K | 225.01% |
| Q1 2024 Q2Q % growth | 325K -84.22% | 325K | % | |
| Q4 2023 Q2Q % growth | 2.034M 10.54% | 1.953M | 81K | 4.15% |
| Q3 2023 Q2Q % growth | 2.185M 27.03% | 2.244M | -59K | -2.63% |
| Q2 2023 Q2Q % growth | 2.09M -16.73% | % | ||
| Q1 2023 Q2Q % growth | 2.06M -29.21% | % | ||
| Q4 2022 Q2Q % growth | 1.84M -34.75% | 2.901M | -1.061M | -36.57% |
| Q3 2022 Q2Q % growth | 1.72M -32.81% | 3.175M | -1.455M | -45.83% |
| Q2 2022 Q2Q % growth | 2.51M -7.38% | 3.008M | -498K | -16.56% |
| Q1 2022 Q2Q % growth | 2.91M 11.92% | 2.535M | 375K | 14.79% |
| Q4 2021 Q2Q % growth | 2.82M 19.49% | 2.754M | 66K | 2.40% |
| Q3 2021 Q2Q % growth | 2.56M 7.56% | 2.475M | 85K | 3.43% |
| Q2 2021 Q2Q % growth | 2.71M 18.86% | 2.433M | 277K | 11.39% |
| Q1 2021 Q2Q % growth | 2.6M -9.72% | 2.911M | -311K | -10.68% |
| Q4 2020 Q2Q % growth | 2.36M 6.79% | 2.754M | -394K | -14.31% |
| Q3 2020 Q2Q % growth | 2.38M 2.59% | 2.605M | -225K | -8.64% |
| Q2 2020 Q2Q % growth | 2.28M 18.75% | 2.352M | -72K | -3.06% |
| Q1 2020 Q2Q % growth | 2.88M 50.00% | 1.989M | 891K | 44.80% |
| Q4 2019 Q2Q % growth | 2.21M | 2.059M | 151K | 7.33% |
| Q3 2019 Q2Q % growth | 2.32M | 1.895M | 425K | 22.43% |
| Q2 2019 Q2Q % growth | 1.92M | 1.763M | 157K | 8.91% |
| Q1 2019 Q2Q % growth | 1.92M | 1.833M | 87K | 4.75% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.1% | -2.77% | -1.18% | 6.39% |
| Revenue | 3.19% | 53.31% | 2.29% | 41.42% |